Advertisement
Home American Society of Hematology 2021

American Society of Hematology 2021

Genomic and Systemic Metabolism Differences Associated with Racial Disparities in Multiple Myeloma

Abstract Background: Racial disparities exist in the prevalence of multiple myeloma (MM) and monoclonal gammopathy of unknown significance (MGUS), with significantly higher prevalence in African...

Association between the Leukemia Mortality-to-Incidence Ratio and State Geographic Healthcare Disparities in the United...

Abstract INTRODUCTION: Leukemia is the seventh leading cause of cancer death in the United States (US) in 2021. The Mortality Incidence Rate Ratio, also known...

Race-Ethnic Enrollment Disparities over 15 Years of Alliance/CALGB Acute Myeloid Leukemia Clinical Trials, Biobanks,...

Abstract Introduction: Race-ethnic disparities in clinical trial enrollment have the potential to bias findings, limit generalizability, misdirect drug development, and reduce equitable access to novel...

Study Finds First-Line Targeted Treatment for CLL Is Beneficial in Elderly Patients

Although individuals older than 80 years make up more than 20% of cases of chronic lymphocytic leukemia (CLL), this population is underrepresented in clinical...

Assessing Costs and Resource Utilization of Hospital-Based Care Among Patients with B-Cell Malignancies

Patients with mantle cell lymphoma (MCL), Waldenström macroglobulinemia (WM), marginal zone lymphoma (MZL), and chronic lymphocytic leukemia (CLL) have high hospital costs associated with...

Age, Tumor Mutations, and Clonal Hematopoiesis Associated with Racial and Ethnic Disparities in Patients...

Racial and ethnic disparities in treatment and mortality are known to exist for patients with multiple myeloma (MM), however, factors driving these disparities and...

SARS-CoV-2 Vaccination May Have Reduced Effectiveness in Patients with Multiple Melanoma

While SARS-CoV-2 vaccination has been proven safe and effective in the general population, patients with multiple myeloma (MM) were not included in vaccination trials,...

Pathologic Germline Variants in Hereditary Cancer Genes Common in Multiple Myeloma

Although multiple myeloma (MM) is known to have an inherited predisposition and pathologic/likely-pathologic germline variants (PGV) in hereditary cancer genes (HCG) are common in...

KRAS/NRAS/BRAF Mutations Associated with Poorer Prognosis in Patients with Multiple Myeloma and Extraosseous/Extramedullary Disease

Extraosseous/extramedullary disease (EMD) plays an important role in the development of relapsed and refractory multiple myeloma (RRMM). However, the molecular biology of EMD development...

Daratumumab-Based Triplet Regimen in Real-World Patients With Relapsed or Refractory Multiple Myeloma

Researchers evaluated real-world data on the combination of daratumumab plus bortezomib and dexamethasone (DVd) after its adoption for treatment of patients with relapsed or...
Advertisement
Advertisement